Three individuals developed minor ocular dryness and erythema at 2, 6, and 8 months from a single ipilimumab infusion without subsequent DLI
Three individuals developed minor ocular dryness and erythema at 2, 6, and 8 months from a single ipilimumab infusion without subsequent DLI. refractory mantle cell lymphoma. In the 3.0 mg/kg dose, active serum concentrations of ipilimumab were maintained for more than 30 days after a single infusion. Ipilimumab, as given in this medical trial, does…